BASHIR AHMED
- Type
- Physician · Allopathic & Osteopathic Physicians / Psychiatry & Neurology / Psychiatry
- Where
- FAIRVIEW, TX
- NPI
- 1659537827
- Received
- $5,027 in 359 records, 2019 to 2025
- Source
- CMS Open Payments search ↗
By year
| Program year | Kind | Records | Amount |
|---|---|---|---|
| 2025 | General payment | 48 | $652 |
| 2024 | General payment | 74 | $1,012 |
| 2023 | General payment | 61 | $915 |
| 2022 | General payment | 77 | $1,108 |
| 2021 | General payment | 71 | $992 |
| 2020 | General payment | 19 | $218 |
| 2019 | General payment | 9 | $127 |
By company
| Company | Records | Amount | Years |
|---|---|---|---|
| ABBVIE INC. | 111 | $1,272 | 2021–2025 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 42 | $679 | 2021–2025 |
| Otsuka America Pharmaceutical, Inc. | 51 | $668 | 2021–2025 |
| Janssen Pharmaceuticals, Inc | 22 | $369 | 2020–2025 |
| Sunovion Pharmaceuticals Inc. | 26 | $319 | 2021–2022 |
| Takeda Pharmaceuticals U.S.A., Inc. | 20 | $298 | 2019–2025 |
| Allergan, Inc. | 17 | $195 | 2019–2020 |
| Tris Pharma Inc | 9 | $168 | 2022–2025 |
| IDORSIA PHARMACEUTICALS US INC | 7 | $134 | 2022–2024 |
| Noven Therapeutics, LLC | 6 | $121 | 2023–2025 |
| Bausch Health US, LLC | 8 | $117 | 2020–2025 |
| Axsome Therapeutics, Inc. | 6 | $109 | 2022–2025 |
| Lundbeck LLC | 6 | $108 | 2022–2024 |
| Supernus Pharmaceuticals, Inc. | 6 | $95 | 2021–2023 |
| Almatica Pharma LLC | 5 | $89 | 2021–2023 |
| E.R. Squibb & Sons, L.L.C. | 3 | $65 | 2024–2025 |
| Alkermes, Inc. | 3 | $49 | 2025 |
| JAZZ PHARMACEUTICALS INC. | 3 | $43 | 2021–2022 |
| Neurocrine BioSciences, Inc. | 3 | $38 | 2019–2020 |
| Teva Pharmaceuticals USA, Inc. | 1 | $25 | 2024 |
| Adlon Therapeutics L.P. | 1 | $19 | 2020 |
| Avion Pharmaceuticals | 1 | $13 | 2023 |
| Shire North American Group Inc | 1 | $12 | 2019 |
| Eisai Inc. | 1 | $12 | 2021 |
By nature of payment
| Nature | Records | Amount |
|---|---|---|
| Food and Beverage | 358 | $5,024 |
| Education | 1 | $3 |
Records
| Date | Company | Amount | Nature | Form | Product | Study | Year |
|---|---|---|---|---|---|---|---|
| 2025-12-05 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $8 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-12-03 | ABBVIE INC. | $9 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-11-17 | E.R. Squibb & Sons, L.L.C. | $19 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-11-12 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $17 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-10-29 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $8 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-10-09 | ABBVIE INC. | $13 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-10-01 | Otsuka America Pharmaceutical, Inc. | $9 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-08-20 | Axsome Therapeutics, Inc. | $16 | Food and Beverage | In-kind items and services | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-08-06 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $17 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-08-04 | Otsuka America Pharmaceutical, Inc. | $9 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-07-11 | ABBVIE INC. | $10 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-07-10 | Alkermes, Inc. | $17 | Food and Beverage | In-kind items and services | LYBALVI Drug, CNS | 2025 | |
| 2025-07-09 | Otsuka America Pharmaceutical, Inc. | $9 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-07-02 | Tris Pharma Inc | $18 | Food and Beverage | In-kind items and services | Dyanavel XR Drug, ADHD | 2025 | |
| 2025-06-28 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $14 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-06-25 | Otsuka America Pharmaceutical, Inc. | $11 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-06-24 | ABBVIE INC. | $14 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-06-09 | Otsuka America Pharmaceutical, Inc. | $7 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-06-03 | ABBVIE INC. | $21 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-05-28 | Takeda Pharmaceuticals U.S.A., Inc. | $17 | Food and Beverage | In-kind items and services | TRINTELLIX Drug, NEUROSCIENCE | 2025 | |
| 2025-04-30 | Otsuka America Pharmaceutical, Inc. | $18 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-04-29 | Janssen Pharmaceuticals, Inc | $24 | Food and Beverage | In-kind items and services | INVEGA SUSTENNA Drug, Neuroscience | 2025 | |
| 2025-04-28 | Bausch Health US, LLC | $20 | Food and Beverage | In-kind items and services | APLENZIN Drug, Neurology | 2025 | |
| 2025-04-23 | Alkermes, Inc. | $15 | Food and Beverage | In-kind items and services | ARISTADA Drug, CNS | 2025 | |
| 2025-04-22 | Otsuka America Pharmaceutical, Inc. | $8 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-04-15 | ABBVIE INC. | $9 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-04-11 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $14 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-04-10 | Otsuka America Pharmaceutical, Inc. | $6 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-04-09 | Noven Therapeutics, LLC | $19 | Food and Beverage | In-kind items and services | Xelstrym Drug, ADHD | 2025 | |
| 2025-04-08 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $13 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-04-08 | ABBVIE INC. | $6 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-03-28 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $17 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-03-20 | ABBVIE INC. | $11 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-03-18 | Alkermes, Inc. | $17 | Food and Beverage | In-kind items and services | LYBALVI Drug, CNS | 2025 | |
| 2025-03-17 | Otsuka America Pharmaceutical, Inc. | $13 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-03-12 | ABBVIE INC. | $9 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-03-06 | ABBVIE INC. | $4 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-03-03 | Otsuka America Pharmaceutical, Inc. | $9 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-02-25 | Otsuka America Pharmaceutical, Inc. | $8 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-02-21 | ABBVIE INC. | $21 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-02-10 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $20 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-02-03 | Otsuka America Pharmaceutical, Inc. | $9 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-01-30 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $14 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-01-27 | ABBVIE INC. | $12 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-01-24 | ABBVIE INC. | $9 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-01-22 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $18 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-01-20 | Otsuka America Pharmaceutical, Inc. | $16 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-01-15 | ABBVIE INC. | $8 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2024-12-18 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $21 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2024 | |
| 2024-12-09 | E.R. Squibb & Sons, L.L.C. | $15 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Psychiatry/Psychology | 2024 | |
| 2024-12-04 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $4 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2024 | |
| 2024-12-03 | ABBVIE INC. | $5 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2024-12-02 | Otsuka America Pharmaceutical, Inc. | $8 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2024 | |
| 2024-11-26 | ABBVIE INC. | $10 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2024-11-25 | Otsuka America Pharmaceutical, Inc. | $25 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2024 | |
| 2024-11-13 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $14 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2024 | |
| 2024-11-12 | ABBVIE INC. | $16 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2024-11-04 | E.R. Squibb & Sons, L.L.C. | $30 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Psychiatry/Psychology | 2024 | |
| 2024-10-30 | ABBVIE INC. | $9 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2024-10-28 | Otsuka America Pharmaceutical, Inc. | $7 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2024 | |
| 2024-10-25 | ABBVIE INC. | $9 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2024-10-23 | Axsome Therapeutics, Inc. | $17 | Food and Beverage | In-kind items and services | Auvelity Drug, Psychology/Psychiatric | 2024 | |
| 2024-10-21 | Otsuka America Pharmaceutical, Inc. | $9 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2024 | |
| 2024-10-16 | ABBVIE INC. | $21 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2024-10-15 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $9 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2024 | |
| 2024-10-10 | ABBVIE INC. | $10 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2024-10-09 | Noven Therapeutics, LLC | $23 | Food and Beverage | In-kind items and services | Xelstrym Drug, ADHD | 2024 | |
| 2024-10-07 | Otsuka America Pharmaceutical, Inc. | $18 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2024 | |
| 2024-09-25 | Otsuka America Pharmaceutical, Inc. | $18 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2024 | |
| 2024-09-24 | ABBVIE INC. | $7 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2024-09-16 | ABBVIE INC. | $6 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2024-09-11 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $15 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2024 | |
| 2024-09-10 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $24 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2024 | |
| 2024-09-03 | Axsome Therapeutics, Inc. | $19 | Food and Beverage | In-kind items and services | Auvelity Drug, Psychology/Psychiatric | 2024 | |
| 2024-08-29 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $9 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2024 | |
| 2024-08-21 | Noven Therapeutics, LLC | $19 | Food and Beverage | In-kind items and services | Xelstrym Drug, ADHD | 2024 | |
| 2024-08-20 | ABBVIE INC. | $7 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2024-08-15 | Otsuka America Pharmaceutical, Inc. | $9 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2024 | |
| 2024-08-13 | Otsuka America Pharmaceutical, Inc. | $13 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2024 | |
| 2024-08-02 | ABBVIE INC. | $8 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2024-08-01 | Otsuka America Pharmaceutical, Inc. | $8 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2024 | |
| 2024-07-24 | ABBVIE INC. | $11 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2024-07-17 | ABBVIE INC. | $7 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2024-07-10 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $13 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2024 | |
| 2024-07-08 | Tris Pharma Inc | $21 | Food and Beverage | In-kind items and services | Dyanavel XR Drug, ADHD | 2024 | |
| 2024-06-25 | ABBVIE INC. | $8 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2024-06-24 | Otsuka America Pharmaceutical, Inc. | $8 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2024 | |
| 2024-06-20 | ABBVIE INC. | $19 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2024-06-19 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $18 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2024 | |
| 2024-06-12 | Otsuka America Pharmaceutical, Inc. | $10 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2024 | |
| 2024-06-05 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $13 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2024 | |
| 2024-05-30 | ABBVIE INC. | $4 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2024-05-29 | Otsuka America Pharmaceutical, Inc. | $15 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2024 | |
| 2024-05-20 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $8 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2024 | |
| 2024-05-15 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $16 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2024 | |
| 2024-05-13 | Janssen Pharmaceuticals, Inc | $16 | Food and Beverage | In-kind items and services | SPRAVATO Drug, Neuroscience | 2024 | |
| 2024-05-08 | Teva Pharmaceuticals USA, Inc. | $25 | Food and Beverage | In-kind items and services | UZEDY Drug, Neurology | 2024 | |
| 2024-05-07 | Otsuka America Pharmaceutical, Inc. | $22 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2024 | |
| 2024-05-07 | ABBVIE INC. | $8 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2024-04-24 | ABBVIE INC. | $9 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2024-04-22 | Otsuka America Pharmaceutical, Inc. | $8 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2024 | |
| 2024-04-16 | Otsuka America Pharmaceutical, Inc. | $17 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2024 | |
| 2024-04-16 | Otsuka America Pharmaceutical, Inc. | $2 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2024 | |
| 2024-04-03 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $18 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2024 | |
| 2024-04-01 | Otsuka America Pharmaceutical, Inc. | $8 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2024 | |
| 2024-04-01 | ABBVIE INC. | $7 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2024-03-28 | ABBVIE INC. | $5 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2024-03-20 | Otsuka America Pharmaceutical, Inc. | $19 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2024 | |
| 2024-03-13 | Lundbeck LLC | $17 | Food and Beverage | Cash or cash equivalent | REXULTI Drug, PSYCHIATRY | 2024 | |
| 2024-03-13 | Otsuka America Pharmaceutical, Inc. | $7 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2024 | |
| 2024-03-12 | IDORSIA PHARMACEUTICALS US INC | $15 | Food and Beverage | In-kind items and services | QUVIVIQ Drug, Insomnia | 2024 | |
| 2024-03-04 | Takeda Pharmaceuticals U.S.A., Inc. | $17 | Food and Beverage | In-kind items and services | TRINTELLIX Drug, NEUROSCIENCE | 2024 | |
| 2024-02-28 | ABBVIE INC. | $15 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2024-02-21 | ABBVIE INC. | $7 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2024-02-21 | ABBVIE INC. | $2 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2024-02-20 | Otsuka America Pharmaceutical, Inc. | $7 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2024 | |
| 2024-02-07 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $18 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2024 | |
| 2024-02-01 | ABBVIE INC. | $10 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2024-01-25 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $22 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2024 | |
| 2024-01-24 | ABBVIE INC. | $17 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2024-01-17 | ABBVIE INC. | $25 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2024-01-10 | ABBVIE INC. | $18 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2023-12-20 | IDORSIA PHARMACEUTICALS US INC | $21 | Food and Beverage | In-kind items and services | QUVIVIQ Drug, INSOMNIA | 2023 | |
| 2023-12-13 | ABBVIE INC. | $18 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2023 | |
| 2023-12-13 | Noven Therapeutics, LLC | $17 | Food and Beverage | In-kind items and services | Xelstrym Drug, ADHD | 2023 | |
| 2023-12-06 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $20 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2023 | |
| 2023-11-29 | ABBVIE INC. | $8 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2023 | |
| 2023-11-15 | IDORSIA PHARMACEUTICALS US INC | $17 | Food and Beverage | In-kind items and services | QUVIVIQ Drug, INSOMNIA | 2023 | |
| 2023-11-10 | ABBVIE INC. | $5 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2023 | |
| 2023-11-09 | ABBVIE INC. | $5 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2023 | |
| 2023-11-08 | Avion Pharmaceuticals | $13 | Food and Beverage | In-kind items and services | Methylphenidate Hydrochloride Drug, Neurology - ADHD medication | 2023 | |
| 2023-10-30 | Noven Therapeutics, LLC | $21 | Food and Beverage | In-kind items and services | Xelstrym Drug, ADHD | 2023 | |
| 2023-10-26 | ABBVIE INC. | $9 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2023 | |
| 2023-10-25 | ABBVIE INC. | $21 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2023 | |
| 2023-10-18 | ABBVIE INC. | $13 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2023 | |
| 2023-10-11 | ABBVIE INC. | $17 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2023 | |
| 2023-10-03 | IDORSIA PHARMACEUTICALS US INC | $22 | Food and Beverage | In-kind items and services | QUVIVIQ Drug, INSOMNIA | 2023 | |
| 2023-09-27 | Tris Pharma Inc | $14 | Food and Beverage | In-kind items and services | Dyanavel XR Drug, ADHD | 2023 | |
| 2023-09-26 | Lundbeck LLC | $12 | Food and Beverage | Cash or cash equivalent | REXULTI Drug, PSYCHIATRY | 2023 | |
| 2023-09-18 | ABBVIE INC. | $14 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2023 | |
| 2023-09-12 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $20 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2023 | |
| 2023-09-07 | IDORSIA PHARMACEUTICALS US INC | $22 | Food and Beverage | In-kind items and services | QUVIVIQ Drug, INSOMNIA | 2023 | |
| 2023-08-30 | ABBVIE INC. | $4 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2023 | |
| 2023-08-29 | Lundbeck LLC | $14 | Food and Beverage | Cash or cash equivalent | REXULTI Drug, PSYCHIATRY | 2023 | |
| 2023-08-28 | Janssen Pharmaceuticals, Inc | $16 | Food and Beverage | In-kind items and services | INVEGA TRINZA Drug, Neuroscience | 2023 | |
| 2023-08-23 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $13 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2023 | |
| 2023-08-16 | ABBVIE INC. | $4 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2023 | |
| 2023-07-26 | ABBVIE INC. | $12 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2023 | |
| 2023-07-12 | Janssen Pharmaceuticals, Inc | $20 | Food and Beverage | In-kind items and services | SPRAVATO Drug, Neuroscience | 2023 | |
| 2023-07-10 | ABBVIE INC. | $6 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2023 | |
| 2023-06-26 | ABBVIE INC. | $13 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2023 | |
| 2023-06-19 | Noven Therapeutics, LLC | $20 | Food and Beverage | In-kind items and services | Xelstrym Drug, ADHD | 2023 | |
| 2023-06-14 | Axsome Therapeutics, Inc. | $19 | Food and Beverage | In-kind items and services | Auvelity Drug, Psychology/Psychiatric | 2023 | |
| 2023-06-12 | ABBVIE INC. | $7 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2023 | |
| 2023-06-05 | ABBVIE INC. | $8 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2023 | |
| 2023-05-22 | Janssen Pharmaceuticals, Inc | $15 | Food and Beverage | In-kind items and services | INVEGA SUSTENNA Drug, Neuroscience | 2023 | |
| 2023-05-22 | ABBVIE INC. | $6 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2023 | |
| 2023-05-17 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $21 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2023 | |
| 2023-05-10 | ABBVIE INC. | $6 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2023 | |
| 2023-05-01 | ABBVIE INC. | $21 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2023 | |
| 2023-04-24 | ABBVIE INC. | $4 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2023 | |
| 2023-04-19 | IDORSIA PHARMACEUTICALS US INC | $21 | Food and Beverage | In-kind items and services | QUVIVIQ Drug, INSOMNIA | 2023 | |
| 2023-04-12 | Tris Pharma Inc | $21 | Food and Beverage | In-kind items and services | Dyanavel XR Drug, ADHD | 2023 | |
| 2023-03-22 | Tris Pharma Inc | $15 | Food and Beverage | In-kind items and services | Dyanavel XR Drug, ADHD | 2023 | |
| 2023-03-21 | Supernus Pharmaceuticals, Inc. | $15 | Food and Beverage | Cash or cash equivalent | QELBREE Drug, PSYCHOLOGY | 2023 | |
| 2023-03-20 | ABBVIE INC. | $7 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2023 | |
| 2023-03-15 | Lundbeck LLC | $24 | Food and Beverage | Cash or cash equivalent | REXULTI Drug, PSYCHIATRY | 2023 | |
| 2023-02-24 | Almatica Pharma LLC | $19 | Food and Beverage | In-kind items and services | LOREEV XR Drug, ANTI-ANXIETY | 2023 | |
| 2023-02-22 | Tris Pharma Inc | $24 | Food and Beverage | In-kind items and services | Dyanavel XR Drug, ADHD | 2023 | |
| 2023-02-22 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $13 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2023 | |
| 2023-02-21 | Otsuka America Pharmaceutical, Inc. | $16 | Food and Beverage | In-kind items and services | ABILIFY MAINTENA Drug, PSYCHIATRY | 2023 | |
| 2023-02-15 | ABBVIE INC. | $16 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2023 | |
| 2023-02-14 | Supernus Pharmaceuticals, Inc. | $13 | Food and Beverage | Cash or cash equivalent | QELBREE Drug, PSYCHOLOGY | 2023 | |
| 2023-02-06 | ABBVIE INC. | $8 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2023 | |
| 2023-02-03 | Tris Pharma Inc | $16 | Food and Beverage | In-kind items and services | Dyanavel XR Drug, ADHD | 2023 | |
| 2023-01-27 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $17 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2023 | |
| 2023-01-24 | Janssen Pharmaceuticals, Inc | $16 | Food and Beverage | In-kind items and services | SPRAVATO Drug, Neuroscience | 2023 | |
| 2023-01-19 | Axsome Therapeutics, Inc. | $14 | Food and Beverage | In-kind items and services | Auvelity Drug, Psychology/Psychiatric | 2023 | |
| 2023-01-18 | Supernus Pharmaceuticals, Inc. | $17 | Food and Beverage | Cash or cash equivalent | QELBREE Drug, PSYCHOLOGY | 2023 | |
| 2023-01-11 | ABBVIE INC. | $7 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2023 | |
| 2023-01-09 | Almatica Pharma LLC | $13 | Food and Beverage | In-kind items and services | CITALOPRAM Drug, ANTI-DEPRESSION | 2023 | |
| 2023-01-06 | ABBVIE INC. | $19 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2023 | |
| 2023-01-04 | Bausch Health US, LLC | $14 | Food and Beverage | In-kind items and services | APLENZIN Drug, Neurology | 2023 | |
| 2022-12-19 | Janssen Pharmaceuticals, Inc | $17 | Food and Beverage | In-kind items and services | SPRAVATO Drug, Neuroscience | 2022 | |
| 2022-12-14 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $26 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2022 | |
| 2022-12-13 | Axsome Therapeutics, Inc. | $21 | Food and Beverage | In-kind items and services | Auvelity Drug, Psychology/Psychiatric | 2022 | |
| 2022-11-29 | Almatica Pharma LLC | $20 | Food and Beverage | In-kind items and services | CITALOPRAM Drug, ANTI-DEPRESSION | 2022 | |
| 2022-11-23 | ABBVIE INC. | $28 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2022 | |
| 2022-11-17 | Supernus Pharmaceuticals, Inc. | $20 | Food and Beverage | Cash or cash equivalent | QELBREE Drug, PSYCHOLOGY | 2022 | |
| 2022-11-16 | IDORSIA PHARMACEUTICALS US INC | $12 | Food and Beverage | In-kind items and services | QUVIVIQ Drug, INSOMNIA | 2022 | |
| 2022-11-15 | ABBVIE INC. | $10 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2022 | |
| 2022-11-15 | ABBVIE INC. | $6 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2022 | |
| 2022-11-11 | Bausch Health US, LLC | $12 | Food and Beverage | In-kind items and services | APLENZIN Drug, Neurology | 2022 | |
| 2022-11-09 | Otsuka America Pharmaceutical, Inc. | $16 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2022 | |
| 2022-11-08 | ABBVIE INC. | $15 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2022 | |
| 2022-11-03 | Lundbeck LLC | $18 | Food and Beverage | Cash or cash equivalent | REXULTI Drug, PSYCHIATRY | 2022 | |
| 2022-11-02 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $22 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2022 | |
| 2022-10-27 | ABBVIE INC. | $21 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2022 | |
| 2022-10-24 | Janssen Pharmaceuticals, Inc | $16 | Food and Beverage | In-kind items and services | SPRAVATO Drug, Neuroscience | 2022 | |
| 2022-10-19 | Supernus Pharmaceuticals, Inc. | $13 | Food and Beverage | Cash or cash equivalent | QELBREE Drug, PSYCHOLOGY | 2022 |
The latest 200 records of 359.
CMS Open Payments: payments and transfers of value that drug and medical device makers and group purchasing organizations report to Medicare, program years 2019 on, as published by CMS (general, research and ownership records; refreshed by CMS each June and January). Links to other records on this site are by name (and state) only.
The area Census
County outline, the place (blue), the tract (orange) and the ZIP center (dot).
In Fairview, TX, county Collin County, TX, state Texas; placed by its city name.
| Measure | Place (city or town) Fairview, TX | County Collin County, TX | State Texas |
|---|---|---|---|
| Population B01003 | 10,783 | 1,163,337 | 30,188,424 |
| Population, 2020 census P1 | 10,372 | 1,064,465 | 29,145,505 |
| Median age B01002 | 49.1 | 37.3 | 35.6 |
| Under 18 B01001 | 22.7% | 24.7% | 25.0% |
| 65 and over B01001 | 30.1% | 11.6% | 13.4% |
| Households B11001 | 4,211 | 416,646 | 10,992,816 |
| Foreign born B05002 | 8.4% | 23.3% | 17.6% |
| Median household income B19013 | $109,347 | $121,600 | $78,476 |
| Median family income B19113 | $137,336 | $145,862 | $94,599 |
| Per capita income B19301 | $62,345 | $57,056 | $40,752 |
| Poverty rate B17001 | 14.8% | 6.2% | 13.8% |
| Unemployment rate B23025 | 4.4% | 4.2% | 5.3% |
| Civilian labor force B23025 | 3,973 | 642,253 | 15,233,563 |
| Mean commute (minutes) B08013 | 33.8 | 28.2 | 26.7 |
| Bachelor's degree or higher B15003 | 59.4% | 56.2% | 33.8% |
| Housing units B25001 | 4,552 | 437,396 | 12,128,515 |
| Owner-occupied B25003 | 73.9% | 64.5% | 62.6% |
| Renters B25003 | 26.1% | 35.5% | 37.4% |
| Median home value B25077 | $597,300 | $475,600 | $283,800 |
| Median gross rent B25064 | $1,947 | $1,859 | $1,403 |
| White, not Hispanic B03002 | 73.9% | 49.6% | 39.1% |
| Black B03002 | 10.3% | 10.8% | 11.9% |
| Hispanic or Latino B03002 | 7.4% | 16.1% | 39.7% |
| Asian B03002 | 4.0% | 18.7% | 5.5% |
| American Indian and Alaska Native B03002 | 0.3% | 0.2% | 0.1% |
Data: IPUMS NHGIS (ACS 2020-2024 and the 2020 census); each figure links to its table for that area at data.census.gov. Records are placed by ZIP code and city name, not street address. More: everything FURP has in Fairview, TX.
Comments